XOMA Limited (NASDAQ:XOMA)

CAPS Rating: 2 out of 5

A biopharmaceutical company that discovers, develops and manufactures antibodies and other genetically-engineered protein products to treat immunological and inflammatory disorders, cancer and infectious diseases.

Recs

0
Player Avatar Fiskhus (71.32) Submitted: 10/4/2012 3:38:50 PM : Outperform Start Price: $3.59 XOMA Score: -18.43

CC+A2+2dVB

Featured Broker Partners


Advertisement